Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus-Michael Debatin

Showing results (1-10 of 301) with videos related to

Pageof 31
Sort By:
Biochemical and Biophysical Research Communications|February 19, 2017
Cell death: From initial concepts to pathways to clinical applications - Personal reflections of a clinical researcherKlaus-Michael Debatin
Molecular and Cellular Pediatrics|November 15, 2015
Molecular and Cellular PediatricsKlaus-Michael Debatin
Cancer Immunology, Immunotherapy : CII|January 30, 2004
Apoptosis pathways in cancer and cancer therapyKlaus-Michael Debatin
Cell|June 2, 2007
Chronic lymphocytic leukemia: keeping cell death at bayKlaus-Michael Debatin
Reviews in Clinical and Experimental Hematology|December 25, 2003
Role of apoptosis in congenital hematologic disorders and bone marrow failureKlaus-Michael Debatin
Onkologie|September 16, 2006
CD95 system counter attack and prognostic impactKlaus-Michael Debatin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
The role of CD95 system in chemotherapyKlaus-Michael Debatin
Blood|December 16, 2017
HSCT cures ADA2 deficiencyKlaus-Michael Debatin
Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
Death receptor signaling in cancer therapySimone Fulda, Klaus-Michael Debatin
Neoplasia (New York, N.Y.)|April 2, 2005
Sensitization for anticancer drug-induced apoptosis by betulinic AcidSimone Fulda, Klaus-Michael Debatin
Pageof 31

Showing results (1-10 of 301) with videos related to

Sort By:
Pageof 31
Biochemical and Biophysical Research Communications|February 19, 2017
Cell death: From initial concepts to pathways to clinical applications - Personal reflections of a clinical researcherKlaus-Michael Debatin
Molecular and Cellular Pediatrics|November 15, 2015
Molecular and Cellular PediatricsKlaus-Michael Debatin
Cancer Immunology, Immunotherapy : CII|January 30, 2004
Apoptosis pathways in cancer and cancer therapyKlaus-Michael Debatin
Cell|June 2, 2007
Chronic lymphocytic leukemia: keeping cell death at bayKlaus-Michael Debatin
Reviews in Clinical and Experimental Hematology|December 25, 2003
Role of apoptosis in congenital hematologic disorders and bone marrow failureKlaus-Michael Debatin
Onkologie|September 16, 2006
CD95 system counter attack and prognostic impactKlaus-Michael Debatin
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
The role of CD95 system in chemotherapyKlaus-Michael Debatin
Blood|December 16, 2017
HSCT cures ADA2 deficiencyKlaus-Michael Debatin
Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
Death receptor signaling in cancer therapySimone Fulda, Klaus-Michael Debatin
Neoplasia (New York, N.Y.)|April 2, 2005
Sensitization for anticancer drug-induced apoptosis by betulinic AcidSimone Fulda, Klaus-Michael Debatin
Pageof 31